LYN Knockout HAP1 Cell Line

The choice depends on whether you are studying LYN's role as a Src-family kinase in B cell receptor signaling or its functions in myeloid cell signaling and cancer biology. The Knockout line is the standard tool for asking whether LYN is required for these processes — LYN is a Src-family tyrosine kinase principally expressed in B cells, myeloid cells, and platelets, with established roles in immune receptor signaling and CLL (chronic lymphocytic leukemia) biology. Overexpression is useful for studying LYN gain-of-function in cancer contexts. Important consideration: Src-family kinases (SRC, LYN, FYN, YES, FGR, HCK, LCK, BLK) share substantial substrate scope — single LYN knockout in HAP1 may show modest phenotypes if other Src-family members compensate. Rescue with wild-type or kinase-dead LYN is the standard specificity control. The knockout is a critical specificity tool for Src-family inhibitors (dasatinib, bafetinib) — bafetinib was investigated specifically for LYN in CLL clinical trials. LYN-specific functions in B cell malignancies make it an emerging cancer target.

Primary applications: • Src-family kinase activity: phospho-LYN (Y397 activation, Y508 autoinhibition) and substrate phosphorylation analysis given LYN's autoregulatory phosphorylation. • BCR signaling: in heterologous B cell-relevant contexts, BCR-induced phospho-SYK, phospho-BLNK, and downstream signaling. • CLL mechanism studies: assessment of LYN-mediated CLL cell survival pathways. • LYN inhibitor specificity: critical genetic control for dasatinib (broad-spectrum SFK inhibitor), bafetinib (LYN/Abl inhibitor investigated for CLL), and other Src-family inhibitors. EDITGENE recommends this model for in vitro LYN biochemistry and pharmacology; physiological B cell LYN research requires B-lineage cell models.

Yes. LYN rescue experiments require attention to Src-family architecture and lipid modifications: • Construct design: use a codon-modified LYN sequence with a small C-terminal tag (FLAG, HA). LYN has N-terminal myristoylation/palmitoylation (membrane anchoring), unique region, SH3, SH2, kinase domain, and C-terminal regulatory tail with Y508 — preserve N-terminus for proper membrane targeting. • Kinase-dead rescue: K275A mutation in the ATP-binding lysine abolishes catalytic activity. • Activating rescue: Y508F mutation removes the autoinhibitory C-terminal phosphorylation site, generating constitutively active LYN. • Lipid-modification-deficient rescue: G2A mutation abolishes myristoylation and membrane association. • Functional readout: rescue should restore Src-family kinase substrate phosphorylation patterns. HAP1-specific considerations: • Diploidization: HAP1 cells gradually diploidize during extended culture — confirm ploidy by flow cytometry at the time of phenotypic assay. • Integration site sensitivity: position effects on transgene expression are more pronounced in near-haploid backgrounds; generating multiple independent rescue clones is strongly recommended. • Transduction efficiency: HAP1 transduces with lentivirus at moderate efficiency — increase MOI compared to standard immortalized lines.